A transparent marketplace for pet owners to compare veterinary costs, track medical history, and coordinate prescription fulfillment through trusted partners.

Is butorphanol safe for my pet if they have heart disease?

Butorphanol can affect heart rate and blood pressure, so it must be used with caution in animals with cardiac disease. Your veterinarian will weigh the risks and benefits based on the severity of the heart condition and the necessity of the procedure.

How long will the effects of butorphanol last?

The analgesic and sedative effects of butorphanol are relatively short-lived, typically lasting between 30 minutes to a few hours depending on the dosage and individual patient metabolism. Its duration is generally shorter than that of other opioids like morphine or methadone.

Can I give butorphanol to my dog for cough at home?

Butorphanol should only be given under strict veterinary supervision. While it has antitussive properties, it is a controlled substance and must be prescribed by a veterinarian who has examined your pet to ensure it is the appropriate treatment for the underlying cause of the cough.

What should I do if my pet seems confused or agitated after receiving butorphanol?

Some animals, particularly cats, may exhibit signs of excitement or dysphoria after opioid administration. If your pet appears unusually agitated, contact your veterinarian immediately, as they may need to adjust the medication or provide a reversal agent.

Does butorphanol cause addiction in pets?

While butorphanol has potential for abuse and is a controlled substance, physical addiction in the human sense is not a typical concern in veterinary patients when used for short-term medical procedures. It must, however, be handled according to strict regulatory standards for controlled drugs.

Anesthetic

Butorphanol (Anesthetic) in Dogs & Cats

Generic: Butorphanol

Butorphanol is a synthetic, centrally acting opioid agonist-antagonist used in veterinary medicine primarily for its potent analgesic and sedative properties.

This medication is intended for dogs and cats.

RxDogs & Cats

Overview

Butorphanol is a potent synthetic opioid that acts primarily as a kappa-opioid receptor agonist and a mu-opioid receptor antagonist, making it a versatile tool in clinical anesthesia and pain management. It is frequently employed in veterinary settings to provide sedation and analgesia for patients undergoing minor surgical procedures or diagnostic imaging. Unlike pure mu-agonists, butorphanol offers a 'ceiling effect' on respiratory depression, which can make it a safer choice in specific, medically compromised patients, though its duration of action for pain relief is often shorter than other opioids like Buprenorphine (Anesthetic).

In the context of balanced anesthesia, butorphanol is commonly integrated into pre-anesthetic protocols. By reducing the overall requirements for induction agents such as Propofol or Alfaxalone, clinicians can achieve a more stable anesthetic plane. It is frequently combined with sedatives like alpha-2 agonists to facilitate chemical restraint or to calm anxious patients before the administration of inhalant anesthetics like Isoflurane or Sevoflurane. Its ability to suppress the cough reflex also makes it a valuable adjunctive therapy in cases of chronic respiratory irritation, provided the cough is non-productive.

Clinicians must carefully evaluate the patient's cardiovascular and respiratory status prior to administration, as individual responses to opioid agents can vary significantly. While it is highly effective for visceral pain and sedation, it may not provide the necessary depth of analgesia for major orthopedic surgeries or severe trauma. Proper titration and monitoring are essential when used in conjunction with other anesthetic adjuncts, such as Ketamine (Anesthetic), to ensure patient safety and optimal anesthetic recovery profiles. Its use remains a cornerstone of multimodal anesthesia protocols across both small and large animal practices.

What It Treats

Mild to moderate visceral pain, often associated with abdominal procedures or medical conditions.
Pre-anesthetic sedation, helping to calm patients before induction agents are administered.
Antitussive effects, used to suppress non-productive coughing in dogs.
Analgesia for minor procedures, such as dental cleanings or radiographic examinations.

How It Works

Butorphanol functions by binding to specific opioid receptors in the central nervous system. As a kappa-opioid agonist, it produces analgesia and sedation with a lower incidence of the severe respiratory depression associated with pure mu-opioid agonists. By simultaneously acting as a weak mu-opioid antagonist, it may reverse the effects of other mu-agonist opioids, which is why its clinical application requires careful consideration of the patient's entire drug regimen. The drug is rapidly metabolized by the liver and excreted through the urine and feces. Its primary effect is mediated through the inhibition of ascending pain pathways and the alteration of the perception of and response to pain at the spinal and supraspinal levels. This dual-action profile allows for a nuanced effect on the patient's autonomic nervous system, generally leading to mild sedation and effective pain modulation during short-duration procedures.

Dosage

Dosage is highly variable depending on the species, the intended use (sedation vs. analgesia), the patient's health status, and other medications being administered simultaneously. There is no standard 'one-size-fits-all' dose. Veterinarians calculate the exact dosage based on the patient's weight, clinical history, and the specific procedure requirements. Always follow the precise dosage and schedule prescribed by your attending veterinarian to avoid adverse reactions or inadequate pain control.

Administration

Butorphanol is typically administered via intravenous (IV), intramuscular (IM), or subcutaneous (SC) injection by veterinary professionals. The route of administration is chosen based on the desired onset of action and the clinical setting. Intravenous administration provides the most rapid onset, while IM or SC routes offer a more gradual effect. Oral formulations may exist for specific antitussive purposes in dogs, but the injectable form is standard for anesthetic protocols.

Storage

Butorphanol should be stored in a secure, climate-controlled environment, typically at room temperature (between 20°C and 25°C or 68°F to 77°F). It must be protected from light and kept away from reach of children and unauthorized personnel, as it is a controlled substance. Always ensure the container is tightly closed and check the expiration date prior to use.

Contraindications

Butorphanol is generally contraindicated in patients with known hypersensitivity to the drug or other opioid derivatives. It should be used with extreme caution in animals with severe liver or kidney disease, as these organs are responsible for the metabolism and excretion of the drug, and impaired function can lead to prolonged or exaggerated effects. Additionally, butorphanol should be avoided or used with significant caution in patients with severe head trauma, increased intracranial pressure, or hypothyroidism. Because of its potential to alter cardiovascular function, it is generally not the first choice for patients with severe cardiac disease or those in a state of shock where blood pressure regulation is already compromised.

Interactions

Butorphanol can significantly potentiate the effects of other central nervous system (CNS) depressants. When used concurrently with tranquilizers, sedatives, general anesthetics, or antihistamines, the risk of profound respiratory depression, profound sedation, and cardiovascular instability increases. Clinicians must perform dosage adjustments when combining butorphanol with other CNS agents. Furthermore, because of its mu-antagonist properties, butorphanol may partially or completely reverse the analgesic effects of pure mu-opioid agonists if they have been administered previously. This interaction is clinically significant in patients requiring deep pain management, as the switch to or addition of butorphanol may result in inadequate pain control.

Side Effects

Sedation or lethargy
Ataxia (loss of coordination)
Bradycardia (slow heart rate)
Respiratory depression (typically mild, dose-dependent)
Hypotension
Gastrointestinal upset (vomiting, anorexia)
Excitement or dysphoria (rare, particularly in cats)
Excessive salivation

Sources & References

Frequently Asked Questions

This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.

Find a Pharmacy